建議

司在導入 SMP 時，完全以財務指標和產能利用率及產能的實際需求來作 規劃，以致於一種藥品的生產可能僅在一個生產中心生產，雖然易達到經濟規模，若 一

面對變化快速的市場商情，降低經營成本與創造新的顧 客價值，是非常需要供應鏈管理制度。

富、土地廉價、交 通便利、勞力充足的地區投資，建立生產據點，以降低製造成本及管銷費用。

個案公

旦有狀況發生，而產生生產停頓之情形，將直接影響到供貨能力。因此建議個案公 司在作產品分工時，應考慮到任何一個產品至少由兩個生產中心生產，並有足夠之預 備產能，以避免因一生產中心無法順利生產而發生供貨的問題。

個案公司有 80%的訂單量來自少數的大醫院，建議應將供應鏈管理庫存的模式透 過各地的系統向下延伸到那些大醫院，以獲得更多的資訊，如此一來，必定可以更有 效地提升需求預測的準確度，使整個供應鏈管理產生另一正向循環，而使個案公司更 具競爭力。另外在產能的規劃上，個案公司亦可考慮外包的產能，可將一些較成熟的 產品外包給一些評估合格的小 GMP 藥廠製造，將自己的產能用於生產較高附加價值 的產品，以使單位產值增加，而提高投資報酬率。在產業進入成熟期後，產品的毛利 微薄，企業面臨不少經營瓶頸，推動供應鏈管理制度，以健全經營體制及提升經營競 爭力，往往可使企業位於不敗之地。供應鏈管理制度是企業的競爭力奇兵，尤其為因 應二十一世紀的競爭趨勢，在

現代企業經營已經不能自外於國際市場，面臨來自全球的競爭，效率、服務、品質 和成本控制就成為決勝的必要條件。企業需要透過電腦科技的進步，運用整合的系統，

使企業得以即時且精確的掌握各地廠房的生產進度、庫存，出貨狀況與財物流通現狀，

以最快的速度滿足客戶的需求。以全球供應鏈管理的策略，使企業得以有效地縮短運 銷支援時間，與降低運送成本，如何快速地以最合理的成本，將產品送達國際市場上 每一顧客手中，這也是個案公司須儘速解決的課題之一。

全球供應鏈管理與全球運籌(Logistics)管理已成為今日企業擬訂競爭策略中重要 的一環，無論在降低成本、強化品質、創造價值或產品區隔等方面，都需將全球供應 鏈管理納入策略考量。為因應全球分工與運籌管理趨勢，構建跨國分工體系，並建立 研究發展及全球運籌管理中心，以及在海外尋覓原料及能源供應豐

參考文獻

1.

2.

inthicum, Sep 2001.

3. Beamon, B.M., “Supply Chain Design and Analysis: Models and Methods,” International Journal of P

4.

1 nancial Times, Irwin, 1994.

12. Collins, T., “Striking it big together,” Supply Management, Vol. 4, Iss. 18, pp28-30, Sep 19

1

1 endor

Managed Inventory system,” Computers & Industrial Engineering, Vol. 43, Iss. 1, 2, pp.

27, New York, Jul 2002.

15. Dong, Y., “A supply chain model of vendor managed inventory,” Transportation Research Part E, Vol. 38E, Iss. 2, pp. 75, Apr 2002.

16. Ellram, L.M., “Supply Chain Management,” International Journal of Physical Distribution and Logistics Management, Vol. 21, Iss. 1, pp.13-33, pp.57-58, 1991.

17. Ganeshan, R. and T.P., Harrison, “An Introduction to Supply Chain Management,

“ Department of Management Science and Information System, Penn State University, 1998, (http://silmaril.smeal.psu.edu/ misc/supply_Chain_intro.html.)

Apte, U.M., “Strategic and technological innovations in supply chain management,”

International Journal of Manufacturing Technology and Management, Vol. 4, Iss. 3.4, pp.

264, Geneva, 2002.

Axsater, S., “A note on stock replenishment and shipment scheduling for vendor-managed inventory systems,” Management Science, Vol. 47, Iss. 9, pp. 1306, L

roduction Economics, Vol. 55, pp.281-294, 1998.

Bowersox, D.J., and D.J., Closs, Logistical Management – The Integrated Supply Chain Process, McGraw-Hill, New York, 1996.

Carter, J.R., and B.G., Ferrin, Carter, “The impact of Transportation Cost and Supply Chain Management,” Journal of Business Logistics, Vol. 16, Iss. 1, pp.189-212, 1994.

Cetinkaya, S., “Stock replenishment and shipment scheduling for vendor-managed inventory systems,” Management Science, Vol. 46, Iss. 2, pp. 217-32, Linthicum, Feb 2000.

Challener, C., “Taking the VMI step to collaborative commerce,” Chemical Market Reporter, Vol. 258, Iss. 21, pg. FR11, 2 pgs, New York, Nov 2000.

haouch, B.A., “Stock levels and delivery rates in vendor-managed inventory programs,”

Production and Operations Management, Vol. 10, Iss. 1, pp. 31-44, Muncie, Spring 2001.

Cheung, K.L., “The inventory benefit of shipment coordination and stock rebalancing in a supply chain,” Management Science, Vol. 48, Iss. 2, pp. 300-306, Linthicum, Feb 2002.

0. Chopra, S., and P., Meindl, Supply Chain Management, Prentice Hall, New Jersey, 2001.

1. Christopher, M., Logistics and Supply Chain Management, Fi 99.

3. Cooper, M.C. and L.M., Ellram, “Characteristics of Supply Chain Management and the Implications for Purchasing and Logistics Strategy,” The International Journal of Logistics Management, Vol. 4:2), pp.13-24, 1993.

4. Disney, S.M., “A procedure for the optimization of the dynamic response of a V

62

18. Haavik, S., “Building a demand-d r-managed supply chain,” Healthcare Financial Management, Vol. 54, Iss. 2, pp. 56-60, Westchester, Feb 2000.

20. .F., Wood, Contemporary Logistics, 6th edition, Upper Saddle River, 21.

22. nagement: Implementation

25. aufmann, Seminar on Strategy Management, Shanghai, 2004.

ry,” Decision Science, 27.

riven, vendo

19. Harrington, L.H., “Focus on Pharmaceuticals: Put Good Ideas to work,” Transportation

＆ Distribution, pp. 41-46, 1999.

Johnson, J.C., and D

Prentice Hall, New York, 1996.

Kalakota, R., and A.B., Whinston,著，<<電子商務管理指南(Electronic Commerce：A Managers Guide)>>，陳雪美譯，翔威出版，1998。

Lamber, D.M., M.C., Cooper, and J., Pagh, “Supply Chain Ma

Issues and Research Opportunities,” The International Journal of Logistics Management, vol. 9, No. 2, pp. 1-19, 1998.

23. Langnau, L., “Inventory management is key in retailing,” Material Handling Management, Vol. 56, Iss. 8, pp. 35-37, Cleveland, Aug 2001.

24. Lenius, P., “PVF supply chain management in the real world,” Supply House Times, Vol.

45, Iss. 4, pp. 28-34, Troy, Jun 2002.

Lutz K

26. Mabert, V.A., and M.A., Venkataramanan, “Special Research Focus on Supply Chain Linkages: Challenges for Design and Management for the 21^st Centu

vol. 29, No. 3, pp. 537-552, 1998.

Metz, P.J., “Demystifying Supply Chain Management,” Supply Chain Management Review, winter, 1998.

Also at http://www.manaufacturing.net/magaz---gistic/archives/1998/scmr/myst.htm

28. Page, M., “How to Sweeten Your Supply Chain,” Proceedings of BPICS Annual

rise: Techniques Applied, Culture Change Challenges Met and Benefits Realized,”

30. any: The Flexible Facility Decision,”

31.

Press, pp. 54, Boston, 1987.

Conference, Vol. 5, Iss. 3, pp.21-26, 1989.

29. Petrich, R.P., and J.J., Curry, “Supply Chain Innovation in Global Multi-Business Enterp

Annual Conference Proceedings, Vol. 11, Iss. 14, pp.39-66, Anaheim, California, October 1998.

Pisano, G., and Rossi, S., “Eli Lilly and Comp

Harvard Business School Case Services, Boston, Mass, April 21, 1994.

Pisano, G., “The development Factory: Unlocking the Potential of Process Innovation “:

Harvard Business School

32. Poirier, C.C., and S.E., Reiter,著，強勢供應鏈，蔡翠旭譯，書華出版社，台北縣，民 國 87 年。

33. Porter, M.E., Competitive Advantage, The Free Press, New York, 1985.

Quinn, F.J., “Building a World-Class Supply Chain,” Logistics Management Distr

34. ibution

35.

Report, Sep. 1990, pp.32-40.

Scouras, I., “The success of VMI programs depends on the health of the industry,” EBN,

Iss. 1331, pp. 26, Manhasset, Sep 2002.

Simchi-Levi, D., P., Kaminsky, and E., Smichi-Levi, Designing and Manag

36. ing the Supply

37. International Journal of Distribution and

38. y, McGraw-Hill, 1997.

, pp. 59, Rockville, May 2000.

41. 未來」，<<資訊與電腦>>，50-51 頁，2000 年 4 月。

43. 十 一 世 紀 的 明 星 產 業 」，

Chain: Concepts, McGraw-Hill, 2000.

Stevens, G.C., “Integrating the Supply Chain,”

physical Materials Management, Vol. 19, Iss. 8, pp.3-8, 1989.

Tapscott, D., The Digital Econom

39. Williams, M.K., “Making Consignment- and Vendor- Managed Inventory Work for You.”

Hospital Materiel Management Quarterly, Vol. 21, Iss. 4

40. 王正忠，「署立醫療院所導入供應鏈管理關鍵成功因素之研究-以中區聯盟醫療院所 為例」，國立中正大學，碩士論文，2003。

果云，「供應鏈管理的現在及

42. <<醫藥產業年鑑>>，生物技術開發中心，2003。

蘇 遠 志 ，「 生 技 產 業 簡 介 ─ 二

http://www.bookzone.com.tw:81/gate/gb/www.bookzone.com.tw/event/helix/report.htm。

韓復華，全球運籌管理課程講義，交

44. 通大學，民國九十一年。

64

附錄

個案

個案公司產品介紹

公司產品如下:

• 生產之產品供應全世界 191 個國家

• 產品品牌有 1, 200 種

• 製造量每年有 4 billion packs

• 產品包裝每年有 28, 000 種

• 貨品重量每年 6, 000 噸

• 每年有新產品 2, 000 種

主要產品如下:

Anti-Allergics (抗敏感藥) 　 Beconase^TM鼻可靈^TM 　 Flixonase^TM輔舒良^TM 　 Semprex^TM新敏樂^TM

Anti-Asthmatics (哮喘藥) 　 Becloforte^TM必可復^TM 　 Becodisks^TM必酮碟^TM 　 Becotide^TM必可酮^TM 　 Flixotide^TM輔舒酮^TM 　 Seretide^TM舒悅泰^TM 　 Serevent^TM施立穩^TM 　 Ventide^TM喘樂酮^TM 　 Ventodisks^TM喘寧碟^TM 　 Ventolin^TM喘樂寧^TM 　 Volmax^TM喘特寧^TM

Anti-Bacterials (抗生素) 　 Amoxil^TM

　 Ampiclox^TM 　 Augmentin^TM 　 Bactroban^TM

　 Ceporex^TM西保力^TM

　 Monocid^TM 　 Neosporin^TM 　 Orbenin^TM 　 Otosporin^TM 　 Penbritin^TM 　 Polyfax^TM 　 Septrin^TM 　 Timentin^TM

　 Zinacef^TM西力欣^TM 　 Zinnat^TM新菌靈^TM

Anti-Emetics (止嘔吐藥) 　 Marzine^TM

　 Valoid^TM

　 Zofran^TM樞復寧^TM Anti-Inflammatory (抗炎藥) 　 Relifex^TM

Anti-Ulcerants (抗潰瘍藥) 　 Pylorid^TM百樂威^TM 　 Tagamet^TM

　 Zantac^TM善胃得^TM Anti-Virals (抗病毒藥) 　 3TC^TM欣平芝^TM 　 Combivi^TM

　 Relenza^TM樂感清^TM Retrovir

　 ^TM

　 Valtrex^TM維德思^TM 　 Wellferon^TM惠福仁^TM 　 Ziagen^TM

　 Zeffix^TM怡干樂^TM 　 Zovirax^TM適患療^TM

Cardiovascular (心血管藥)

66

　 Angised^TM 　 Cartia^TM

　 Lacipil^TM朗適平^TM 　 Lanoxin^TM

　 Trandate^TM湍泰低^TM

Central Nervous System (中樞神經藥) 　 Imigran^TM英明格^TM

　 Lamictal^TM利必通^TM 　 Migril^TM

Requip 　 ^TM 　 Seroxat^TM

Dermatologicals (皮膚藥) 　 Betnesalic^TM裨舒適^TM

Betnovate^TM裨乃膚^TM

　

　 Betnovate-C^TM裨乃膚^TM-C 　 Betnovate-N^TM裨乃膚^TM-N

Cutivate

　 ^TM克廷膚^TM 　 Dermovate^TM特美膚^TM 　 Eumova et ^TM悠美膚^TM

Muscle Relaxants (肌肉鬆馳劑) Mivacron

　 ^TM美維松^TM 　 Nimbex^TM賽機寧^TM 　 Tracr miu ^TM卡肌寧^TM

Nutritional Drink (健康飲料) 　 Horlicks^TM好立克^TM 　 Lucozade^TM葡萄適^TM 　 Ribena^TM利賓納^TM

Oncologicals (腫瘤科藥) 　 Alkeran^TM愛克蘭^TM

Hycamtin 　 ^TM

　 Leukeran^TM留可然^TM 　 Myleran^TM馬利蘭^TM 　 Puri-Nethol^TM

Oral Care (口腔護理) Aquafresh

　 ^TM家護^TM口腔護理 　 Corsodyl^TM

OTC (非處方藥)

　 Beechams Hot Lemon^TM美占熱檸檬^TM 　 Calpol^TM家寶^TM退燒藥水

　 Celin^TM甜CC^TM維他命C軟糖 Coldrex

　 ^TM可立治^TM 　 Cortal^TM克痛^TM

　 Dequadin^TM得果定^TM喉片 　 Drapolene^TM寶嬰^TM尿疹膏 　 Eno^TM以羅^TM果子鹽 　 Eye Mo^TM安寧^TM眼藥水 　 Oxy^TM快治^TM

　 Panadol^TM必理痛^TM

　 Panadol Cold & Flu^TM必理痛傷風感冒^TM產品 Piriton

　 ^TM百利通^TM敏感丸 　 Scott's^TM司各脫^TM魚肝油 　 Valda^TM樺達^TM潤喉糖

　 Zovirax^TM Cold Sore Cream適患療^TM唇瘡膏 Others (其他)

　 Actifed^TM 　 Avandia^TM 　 DF118^TM

　 Eltroxin^TM愛初新^TM 　 Exosurf^TM

　 Imuran^TM依木蘭^TM 　 Malarone^TM

　 Physeptone^TM

68

　 Sudafed^TM

　 Ultiva^TM痛速寧^TM 　 Wellconal^TM

Zyloric

　 ^TM賽來力^TM 　 Zyban^TM熄健^TM

Vaccine (疫苗) Engerix 　 ^TM-B 　 Fluarix^TM 　 Havrix^TM 　 Hiberix^TM 　 Infanrix^TM

　 Infanrix^TM Hep B 　 Priorix^TM

　 Twinrix^TM 　 Varilrix^TM

在文檔中 以個案研究探討製藥產業之供應鏈管理 (頁 71-79)